Company Dascristofarm Srl with Fiscal Code 14421352
recorded a turnover of 2024 of
29.445,
with a net profit of
14.169
and having an average number of employees of
1.
The company operates in the field of Activităţi veterinare having the NACE code 7500.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Dascristofarm Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
23.810
19.839
17.947
11.917
6.212
15.895
28.124
29.003
23.246
29.445
Total Income - EUR
23.813
19.847
17.961
11.935
6.229
15.901
28.142
29.019
23.267
29.460
Total Expenses - EUR
12.244
9.777
9.339
9.219
3.804
5.704
11.760
15.892
18.592
14.996
Gross Profit/Loss - EUR
11.569
10.070
8.622
2.715
2.425
10.197
16.382
13.127
4.675
14.464
Net Profit/Loss - EUR
10.855
9.771
8.442
2.561
2.238
10.078
16.228
12.837
4.442
14.169
Employees
3
1
1
0
0
0
2
2
2
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 27.4%, from 23.246 euro in the year 2023, to 29.445 euro in 2024.
The Net Profit increased by 9.752 euro, from 4.442 euro in 2023, to 14.169 in the last year.
Check the financial reports for the company - Dascristofarm Srl
Financial Rating - DASCRISTOFARM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Dascristofarm Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Dascristofarm Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Dascristofarm Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
29.501 euro in 2024 which includes Inventories of
2.199 euro, Receivables of
4.167 euro and cash availability of
23.135 euro.
The company's Equity was valued at
25.074 euro, while total Liabilities amounted to
21.870 euro.
Equity increased by 14.169 euro, from 10.966 euro in 2023, to 25.074 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Dascristofarm Srl